On August 5, Edgewell Personal Care (NYSE:EPC) reported third quarter fiscal 2026 results for the period ended June 30, and the numbers tell two different stories at once. Organic net sales grew for the first time in a while, and North America finally showed real life. But the profit line tells a rougher tale, with operating income nearly cut in half. CEO Rod Little called it “an important step forward,” and the back half of the fiscal year is where that claim gets tested.
North America Finally Turns The Corner
Net sales came in at $570.1 million, up 1.7% from a year ago, with organic net sales rising 1.1%. The real story sits inside that number. North America organic sales grew 3.0%, with volume gains across Sun, Skin Care and Grooming that the company attributes to better execution, wider distribution and momentum in its priority brands. That is the segment investors have been waiting on for quarters. The Sun and Skin Care category backed it up, with net sales up 5.7% and organic sales up 5.0%, powered by mid-single-digit Sun Care growth in North America and strong Grooming and Skin Care performance globally.
Adjusted EPS held at $0.72, matching the prior year and beating what the company had been signaling, while adjusted EBITDA of $78.9 million came in ahead of plan. Interest expense dropped to $16.7 million from $19.4 million, a direct result of paying down the revolving credit facility with proceeds from the Feminine Care divestiture. With $397.1 million in cash and another $418.8 million available on that facility, Edgewell still has room to keep funding its turnaround while paying a $0.15 per share dividend.
Margins Take A Real Hit
The cost side of the business is where the quarter gets uncomfortable. Gross margin fell 210 basis points to 42.5%, and even the adjusted figure slipped 30 basis points to 44.5%, as core inflation and tariffs outran productivity savings. Advertising spending jumped to 14.6% of sales from 13.6%, and SG&A climbed to 19.0% from 18.0%, driven partly by higher incentive compensation. Add $24.5 million in restructuring charges for the quarter, and operating income collapsed to $25.0 million from $45.0 million, while GAAP diluted EPS dropped to $0.26 from $0.46.
The Wet Shave segment did not help, with organic sales down 1.9% on private label supply constraints tied to the company’s own manufacturing consolidation, and segment profit falling nearly 25% on an organic basis. International sales also declined 1.4%, hurt by disruption from the conflict in the Middle East. Full-year restructuring costs are now expected to reach roughly $92 million, up from the prior $90 million estimate, and adjusted net debt leverage still sits at 3.7 times.
Wall Street Turns More Cautious
Hedge fund ownership of Edgewell fell from 20 funds to 15 in the most recent quarter, which points to institutions trimming rather than adding. Short interest sits at 9.79% of the float, a level that reflects a genuine bear camp rather than passing skepticism. The stock trades at 13.14 times forward earnings, as of September 14, a modest multiple that suggests the market is not pricing in much of a recovery story yet. That combination leaves little room for further disappointment.
The Back Half Now Decides
Edgewell narrowed its full-year outlook, and the underlying midpoints for adjusted EPS and adjusted EBITDA held steady even as the ranges tightened. North America’s return to growth and the strength in Sun and Skin Care give the bull case something concrete to point to. But margin compression, a struggling Wet Shave segment, and international disruption are not small issues to work through in one quarter. For the improvement to stick, North America’s momentum needs to outrun the cost pressures squeezing the bottom line.
READ NEXT: 10 Best Future Stocks to Buy Under $10 and 12 Best Performing Semiconductor Stocks to Invest In.
